NASDAQ:RGNX
REGENXBIO Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.regenxbio.comipo date
Sep 17, 2015
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene ...Show More
Earnings
Earnings Release in 5 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus